Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.

GREY:ISOLF - Post by User

Isodiol International Inc

Bullboard Posts

Post by LordoftheMarketon Jan 25, 2018 9:13am

107 Views

Post# 27430550

ISOL Fundamental Research Report

Here's a 20 Page Report written up by Fundamental Research, which is giving ISOL a $2.59 U.S a share Fair Value price Target.

https://bit.ly/2paPCeA

ISOL ISODIOL INTERNATIONAL INC

Here's more proof below that ISOL is still very undervalued in comparison to its market peers in the sector.

ISOL is 6th in revenue for Cannabis stocks trading in Canada. This was put out by new Cannabis Ventures about a week ago. In it you will see ISOL just below ACB in the Revenue Rankings.

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/

Canadian Cannabis Market

Company Name	Stock Symbol	Quarter Ended	Quarterly Sales	Y/Y Growth	Next Financials
Canopy Growth	(TSX: WEED)	09/30/17	C$17.57m	107%	~02/14/18
MedReleaf	(TSX: LEAF)	09/30/17	C$9.82m	-9%	~02/14/18
Aphria	(TSX: APH)	11/30/17	C$8.50m	63%	~04/16/18
Aurora Cannabis	(TSX: ACB)	09/30/17	C$8.25m	169%	~02/14/18
CannTrust	(CSE: TRST)	09/30/17	C$6.14m	680%	~04/30/18
Isodiol International	(CSE: ISOL)	09/30/17	C$5.06m	n/a	~3/01/18
MPX Bioceutical	(CSE: MPX)	09/30/17	C$4.41m	n/a	~3/01/18
CanniMed Therapeutics	(TSX: CMED)	07/31/17	C$4.77m	80%	~1/30/18
Namaste Technologies	(CSE: N)	08/31/17	C$3.82m	336%	~01/29/18